Omicron vaccine is all well and good, but the real money is on an all-in-one jab

Researchers look for alternative strategy as variant-specific vaccines seem doomed to play perpetual catch-up

20 January 2022 - 20:56
By Lisa Jarvis

Researchers look for alternative strategy as variant-specific vaccines seem doomed to play perpetual catch-up

This article is reserved for Sunday Times subscribers.

A subscription gives you full digital access to all Sunday Times content.

Please visit SundayTimes.co.za in your desktop to view our latest subscription options.

Already subscribed? Simply sign in below.

Sign In

Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.